Sandbox/pyelo: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 18: Line 18:
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ceftriaxone]] 1 g IV x 1 dose'''''<BR> OR <BR> ▸ '''''[[Gentamicin]] 7 mg/kg IV x 1 dose'''''<BR> OR <BR> ▸ '''''[[Tobramycin]] 7 mg/kg IV x 1 dose'''''<BR> OR <BR> ▸ '''''[[Amikacin]] 20 mg/kg IV x 1 dose'''''
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ceftriaxone]] 1 g IV x 1 dose'''''<BR> OR <BR> ▸ '''''[[Gentamicin]] 7 mg/kg IV x 1 dose'''''<BR> OR <BR> ▸ '''''[[Tobramycin]] 7 mg/kg IV x 1 dose'''''<BR> OR <BR> ▸ '''''[[Amikacin]] 20 mg/kg IV x 1 dose'''''
|-
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Alternative Regimen'''''
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Alternative Regimen 1'''''
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[TMP/SMZ]] 160/800 mg PO q12h x 14 days '''''
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[TMP/SMZ]] 160/800 mg PO q12h x 14 days'''''
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | PLUS <SMALL>'''(if TMP/SMZ resistance unknown)'''</SMALL>
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | PLUS <SMALL>'''(if TMP/SMZ resistance unknown)'''</SMALL>
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ceftriaxone]] 1 g IV x 1 dose'''''<BR> OR <BR> ▸ '''''[[Gentamicin]] 7 mg/kg IV x 1 dose'''''<BR> OR <BR> ▸ '''''[[Tobramycin]] 7 mg/kg IV x 1 dose'''''<BR> OR <BR> ▸ '''''[[Amikacin]] 20 mg/kg IV x 1 dose'''''
|-
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5;" align=center | '''''Alternative Regimen 2'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Amoxicillin-clavulanate potassium|Amoxicillin–Clavulanate]] 500/125 mg PO q12h x 14 days'''''<BR> OR <BR> ▸ '''''[[Amoxicillin-clavulanate potassium|Amoxicillin–Clavulanate]] 250/125 mg PO q8h x 5–7 days'''''<BR> OR <BR> ▸ '''''[[Cefaclor]] 500 mg PO q8h x 7 days'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | PLUS
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ceftriaxone]] 1 g IV x 1 dose'''''<BR> OR <BR> ▸ '''''[[Gentamicin]] 7 mg/kg IV x 1 dose'''''<BR> OR <BR> ▸ '''''[[Tobramycin]] 7 mg/kg IV x 1 dose'''''<BR> OR <BR> ▸ '''''[[Amikacin]] 20 mg/kg IV x 1 dose'''''
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ceftriaxone]] 1 g IV x 1 dose'''''<BR> OR <BR> ▸ '''''[[Gentamicin]] 7 mg/kg IV x 1 dose'''''<BR> OR <BR> ▸ '''''[[Tobramycin]] 7 mg/kg IV x 1 dose'''''<BR> OR <BR> ▸ '''''[[Amikacin]] 20 mg/kg IV x 1 dose'''''
Line 34: Line 42:
{| style="background: #FFFFFF;"
{| style="background: #FFFFFF;"
| valign=top |
| valign=top |
{| style="float: left; cellpadding=0; cellspacing= 0; width: 400px;"
{| style="float: left; cellpadding=0; cellspacing= 0; width: 500px;"
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Acute Pyelonephritis, Inpatient}}
! style="height: 30px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Acute Pyelonephritis, Inpatient}}
|-
|-

Revision as of 01:34, 23 February 2014




Acute Pyelonephritis, Outpatient
Preferred Regimen
Ciprofloxacin 500 mg PO q12h x 7 days ± Ciprofloxacin 400 mg IV x 1 dose
OR
Ciprofloxacin XR 1000 mg PO q24h for 7 days
OR
Levofloxacin 750 mg PO q24h for 5 days
PLUS (if fluoroquinolone resistance >10%)
Ceftriaxone 1 g IV x 1 dose
OR
Gentamicin 7 mg/kg IV x 1 dose
OR
Tobramycin 7 mg/kg IV x 1 dose
OR
Amikacin 20 mg/kg IV x 1 dose
Alternative Regimen 1
TMP/SMZ 160/800 mg PO q12h x 14 days
PLUS (if TMP/SMZ resistance unknown)
Ceftriaxone 1 g IV x 1 dose
OR
Gentamicin 7 mg/kg IV x 1 dose
OR
Tobramycin 7 mg/kg IV x 1 dose
OR
Amikacin 20 mg/kg IV x 1 dose
Alternative Regimen 2
Amoxicillin–Clavulanate 500/125 mg PO q12h x 14 days
OR
Amoxicillin–Clavulanate 250/125 mg PO q8h x 5–7 days
OR
Cefaclor 500 mg PO q8h x 7 days
PLUS
Ceftriaxone 1 g IV x 1 dose
OR
Gentamicin 7 mg/kg IV x 1 dose
OR
Tobramycin 7 mg/kg IV x 1 dose
OR
Amikacin 20 mg/kg IV x 1 dose



Acute Pyelonephritis, Inpatient
Preferred Regimen
Ciprofloxacin 400 mg IV q12h
OR
Levofloxacin 750 mg IV q24h
OR
Gentamicin 5–7 mg/kg IV q24h
OR
Ceftriaxone 1–2 gm IV q24h
OR
Cefotaxime 2 gm IV q8h
OR
Piperacillin/Tazobactam 3.375 gm IV q4–6h
OR
Ertapenem 1 gm IV q24h
OR
Doripenem 500 mg IV q8h
The choice of antiobiotics should be based on resistance pattern.